Related Articles
Loss of beclin 1 expression in ovarian cancer: A potential biomarker for predicting unfavorable outcomes
Beclin 1 and nuclear factor-κBp65 are upregulated in hepatocellular carcinoma
Expression levels of MRP1, GST-π, and GSK3β in ovarian cancer and the relationship with drug resistance and prognosis of patients
BECN1-knockout impairs tumor growth, migration and invasion by suppressing the cell cycle and partially suppressing the epithelial-mesenchymal transition of human triple-negative breast cancer cells
Effects of CD133 expression on chemotherapy and drug sensitivity of adenoid cystic carcinoma